{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:20:58Z","timestamp":1774423258165,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsthoracicsurgery.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.athoracsur.2024.12.027","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T19:11:42Z","timestamp":1737141102000},"page":"1062-1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of Anticoagulation Therapy After Bioprosthetic and Homograft Pulmonary Valve Replacement"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5235-9483","authenticated-orcid":false,"given":"Alexander K.","family":"Reed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn A.","family":"Sleeper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina J.","family":"VanderPluym","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher W.","family":"Baird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sitaram","family":"Emani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.athoracsur.2024.12.027_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/hrt.2005.071183","article-title":"Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations","volume":"93","author":"Roudaut","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib2","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jacc.2020.11.035","article-title":"2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: executive summary","volume":"77","author":"Otto","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib4","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jacc.2019.06.058","article-title":"Anticoagulation after surgical or transcatheter bioprosthetic aortic valve replacement","volume":"74","author":"Chakravarty","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib5","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1001\/jama.2012.54506","article-title":"Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding","volume":"308","author":"M\u00e9rie","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib6","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.athoracsur.2019.05.068","article-title":"Outcomes of bioprosthetic valves in the pulmonary position in adults with congenital heart disease","volume":"108","author":"Egbe","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jtcvs.2020.06.157","article-title":"Reintervention rates after bioprosthetic pulmonary valve replacement in patients younger than 30 years of age: a multicenter analysis","volume":"161","author":"Baird","year":"2021","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib8","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s00246-014-1089-x","article-title":"Utility of a dedicated pediatric cardiac anticoagulation program: the Boston Children\u2019s Hospital experience","volume":"36","author":"Murray","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.echo.2023.10.004","volume":"37","author":"Zoghbi","year":"2024","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib11","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jtcvs.2011.10.079","article-title":"Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot","volume":"143","author":"Chen","year":"2012","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib13","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jtcvs.2012.09.081","article-title":"Bioprosthetic pulmonary valve replacement: Contemporary analysis of a large, single-center series of 170 cases","volume":"146","author":"Chen","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/ejcts\/ezs219","article-title":"Mid-term results of bioprosthetic pulmonary valve replacement in pulmonary regurgitation after tetralogy of Fallot repair","volume":"42","author":"Jang","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jtcvs.2016.06.064","article-title":"Outcome and performance of bioprosthetic pulmonary valve replacement in patients with congenital heart disease","volume":"152","author":"Nomoto","year":"2016","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.athoracsur.2010.07.111","article-title":"Risk factors for prosthesis failure in pulmonary valve replacement","volume":"91","author":"Zubairi","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib17","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0022-5223(19)34168-6","article-title":"Degeneration of aortic valve allografts in young recipients","volume":"105","author":"Clarke","year":"1993","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib18","first-page":"7","article-title":"Anti \u03b1-Gal immune response following porcine bioprosthesis implantation in children","volume":"19","author":"Park","year":"2010","journal-title":"J\u00a0Heart Valve Dis"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2559.2008.03190.x","article-title":"Bioprosthetic heart valves: modes of failure","volume":"55","author":"Siddiqui","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-5223(95)70282-2","article-title":"Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction","volume":"109","author":"Bando","year":"1995","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jacc.2012.05.029","article-title":"Early anticoagulation of bioprosthetic aortic valves in older patients","volume":"60","author":"Brennan","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib22","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jtcvs.2004.11.028","article-title":"Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?","volume":"129","author":"Sundt","year":"2005","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib23","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jtcvs.2009.10.064","article-title":"Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?","volume":"139","author":"ElBardissi","year":"2010","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib24","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.jacc.2016.09.958","article-title":"Prosthetic heart valve thrombosis","volume":"68","author":"Dangas","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.athoracsur.2024.12.027_bib25","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jtha.2023.03.005","article-title":"Real-world use of apixaban for the treatment and prevention of thrombosis in children with cardiac disease","volume":"21","author":"VanderPluym","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7","key":"10.1016\/j.athoracsur.2024.12.027_bib26","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300067","article-title":"Apixaban or warfarin in patients with an On-X mechanical aortic valve","volume":"2","author":"Wang","year":"2023","journal-title":"NEJM Evidence"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497525000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497525000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:47:15Z","timestamp":1774417635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497525000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0003497525000165"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2024.12.027","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Anticoagulation Therapy After Bioprosthetic and Homograft Pulmonary Valve Replacement","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2024.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by The Society of Thoracic Surgeons. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}